This is an interview with Gary Harlem, CEO of Altucell, a company exploring novel cell therapy approaches to treating Type I diabetes. In addition to diabetes, the company’s core encapsulation technology is applicable to a wide range of autoimmune and chronic degenerative disorders.
While Altucell is an American company, it has secured intellectual property rights on encapsulation patents from a team of researchers at the University of Perugia, Italy, led by Dr. Riccardo Calafiore, M.D. [Read more…]